Download
s00277-021-04461-8.pdf 520,53KB
WeightNameValue
1000 Titel
  • Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80—results from a single-center survey
1000 Autor/in
  1. Freudenberger, Felix |
  2. Ohler, Anke |
  3. Theobald, Matthias |
  4. Hess, Georg |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-25
1000 Erschienen in
1000 Quellenangabe
  • 100(4):1013-1021
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00277-021-04461-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960616/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The prognosis of elderly patients diagnosed with diffuse large B cell lymphoma (DLBCL) is considered to be clearly inferior to that of younger patients. Besides tumor biology and comorbidities, treatment selection due to an assumed reduced tolerability may contribute to this difference. With increasingly more patients diagnosed at advanced age, current treatment selections need to be reviewed carefully. Hence, we analyzed the results of patients above the age of 70 in whom a diagnosis of DLBCL was made. Whereas patients up to 80 were frequently selected for and were able to tolerate standard treatment (86% intended use, 74% completion), patients above the age of 80 years were not only treated more cautiously (67 and 60%, respectively) but did show inferior response to treatment with standard treatment (CR rate for intended R-CHOP use 64% vs. 43%). However, on an individual level, patients receiving and completing standard treatment obtained results that resemble the results of younger patients, irrespective if aged more than 80 and impose superior to prior reports in this age cohort. Median PFS for the entire group of patients was 3.44 years, with 4.83 years for patients below 80 and only 1.09 years for patients above the age of 80. The corresponding figures for OS were 7.38 years (estimated); after 2 years, OS was 81% in the younger cohort in contrast to 68% in patients > 80 years. However, for patients not planned to receive or not tolerating R-CHOP, results remain poor; tailored approaches for these patients are required.
1000 Sacherschließung
lokal Age Factors [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Aggressive lymphoma
lokal Progression-Free Survival [MeSH]
lokal Rituximab/administration
lokal Cyclophosphamide/administration
lokal Original Article
lokal Male [MeSH]
lokal Doxorubicin/administration
lokal Geriatric patients
lokal Combined Modality Therapy [MeSH]
lokal Treatment
lokal Lymphoma, Large B-Cell, Diffuse/radiotherapy [MeSH]
lokal Radiotherapy, Adjuvant [MeSH]
lokal Vincristine/administration
lokal Anthracyclines/administration
lokal Female [MeSH]
lokal Lymphoma, Large B-Cell, Diffuse/drug therapy [MeSH]
lokal Kaplan-Meier Estimate [MeSH]
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Lymphoma, Large B-Cell, Diffuse/epidemiology [MeSH]
lokal Antineoplastic Combined Chemotherapy Protocols/administration
lokal Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH]
lokal Prednisone/administration
lokal Prognosis [MeSH]
lokal Lymphoma, Large B-Cell, Diffuse/mortality [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/RnJldWRlbmJlcmdlciwgRmVsaXg=|https://frl.publisso.de/adhoc/uri/T2hsZXIsIEFua2U=|https://frl.publisso.de/adhoc/uri/VGhlb2JhbGQsIE1hdHRoaWFz|https://orcid.org/0000-0002-9282-5688
1000 Hinweis
  • DeepGreen-ID: ba214f1f6f1e42e6bcdd0a596368759a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6447851.rdf
1000 Erstellt am 2023-05-03T16:37:30.718+0200
1000 Erstellt von 322
1000 beschreibt frl:6447851
1000 Zuletzt bearbeitet 2023-10-20T21:26:25.525+0200
1000 Objekt bearb. Fri Oct 20 21:26:25 CEST 2023
1000 Vgl. frl:6447851
1000 Oai Id
  1. oai:frl.publisso.de:frl:6447851 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source